Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J F Setterfield

Showing results (11-20 of 22) with videos related to

Pageof 3
Sort By:
The British Journal of Dermatology|March 17, 2001
Pyoderma gangrenosum associated with severe oropharyngeal involvement and IgA paraproteinaemiaJ F Setterfield, P J Shirlaw, S J Challacombe, et al.
Clinical and Experimental Dermatology|April 11, 2016
Crescendo response to rituximab in oral pemphigus vulgaris: a case with 7-year follow-upD T Greenblatt, E C Benton, R W Groves, et al.
The British Journal of Dermatology|October 16, 2018
Is the Oral Disease Severity Score going to be useful for dermatologists when assessing pemphigus? Reply from the authorsJ F Setterfield, M Ormond, A N A Donaldson, et al.
Clinical and Experimental Dermatology|June 26, 2003
Clinicopathological case 1: mucous membrane pemphigoid, epidermolysis bullosa acquisita and linear immunoglobulin A diseaseK E Harman, J F Setterfield, P J Shirlaw, et al.
The British Journal of Dermatology|January 23, 2016
Serum and salivary IgG and IgA antibodies to desmoglein 3 in mucosal pemphigus vulgarisS Ali, C Kelly, S J Challacombe, et al.
The British Journal of Dermatology|December 18, 2015
Salivary IgA and IgG antibodies to bullous pemphigoid 180 noncollagenous domain 16a as diagnostic biomarkers in mucous membrane pemphigoidS Ali, C Kelly, S J Challacombe, et al.
The British Journal of Dermatology|August 15, 2009
Genetic analysis of desmoglein 3 (DSG3) sequence variants in patients with pemphigus vulgarisF Capon, H Boulding, M Quaranta, et al.
The British Journal of Dermatology|December 2, 2017
British Association of Dermatologists' guidelines for the management of pemphigus vulgaris 2017K E Harman, D Brown, L S Exton, et al.
The British Journal of Dermatology|January 13, 2006
Evidence of an association between desmoglein 3 haplotypes and pemphigus vulgarisF Capon, J Bharkhada, N E Cochrane, et al.
The British Journal of Dermatology|January 13, 2006
Bullous pemphigoid antigen II (BP180) and its soluble extracellular domains are major autoantigens in mucous membrane pemphigoid: the pathogenic relevance to HLA class II alleles and disease severityN Oyama, J F Setterfield, A M Powell, et al.
Pageof 3

Showing results (11-20 of 22) with videos related to

Sort By:
Pageof 3
The British Journal of Dermatology|March 17, 2001
Pyoderma gangrenosum associated with severe oropharyngeal involvement and IgA paraproteinaemiaJ F Setterfield, P J Shirlaw, S J Challacombe, et al.
Clinical and Experimental Dermatology|April 11, 2016
Crescendo response to rituximab in oral pemphigus vulgaris: a case with 7-year follow-upD T Greenblatt, E C Benton, R W Groves, et al.
The British Journal of Dermatology|October 16, 2018
Is the Oral Disease Severity Score going to be useful for dermatologists when assessing pemphigus? Reply from the authorsJ F Setterfield, M Ormond, A N A Donaldson, et al.
Clinical and Experimental Dermatology|June 26, 2003
Clinicopathological case 1: mucous membrane pemphigoid, epidermolysis bullosa acquisita and linear immunoglobulin A diseaseK E Harman, J F Setterfield, P J Shirlaw, et al.
The British Journal of Dermatology|January 23, 2016
Serum and salivary IgG and IgA antibodies to desmoglein 3 in mucosal pemphigus vulgarisS Ali, C Kelly, S J Challacombe, et al.
The British Journal of Dermatology|December 18, 2015
Salivary IgA and IgG antibodies to bullous pemphigoid 180 noncollagenous domain 16a as diagnostic biomarkers in mucous membrane pemphigoidS Ali, C Kelly, S J Challacombe, et al.
The British Journal of Dermatology|August 15, 2009
Genetic analysis of desmoglein 3 (DSG3) sequence variants in patients with pemphigus vulgarisF Capon, H Boulding, M Quaranta, et al.
The British Journal of Dermatology|December 2, 2017
British Association of Dermatologists' guidelines for the management of pemphigus vulgaris 2017K E Harman, D Brown, L S Exton, et al.
The British Journal of Dermatology|January 13, 2006
Evidence of an association between desmoglein 3 haplotypes and pemphigus vulgarisF Capon, J Bharkhada, N E Cochrane, et al.
The British Journal of Dermatology|January 13, 2006
Bullous pemphigoid antigen II (BP180) and its soluble extracellular domains are major autoantigens in mucous membrane pemphigoid: the pathogenic relevance to HLA class II alleles and disease severityN Oyama, J F Setterfield, A M Powell, et al.
Pageof 3